EcoDrugPlus

F2r Like Thrombin Or Trypsin Receptor 3

Ensembl ID : ENSAMXG00000031906
Gene Symbol: F2RL3
4 Cross references
191 Possible Orthologues:

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSAMXG00000029325
Gene Symbol: FAU
3 Cross references
300 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase B

Ensembl ID : ENSAMXG00000014156
Gene Symbol: FYNB
1 Cross references
201 Possible Orthologues:

G Protein-Coupled Receptor 84

Ensembl ID : ENSAMXG00000025647
Gene Symbol: GPR84
1 Cross references
114 Possible Orthologues:

Gtpase Kras

Ensembl ID : ENSAMXG00000017217
Gene Symbol: LOC103038241
3 Cross references
208 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSAMXG00000036151
Gene Symbol: HCK
3 Cross references
203 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSAMXG00000034758
Gene Symbol: ITK
1 Cross references
208 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSAMXG00000010587
Gene Symbol: JAK1
3 Cross references
214 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSAMXG00000018785
Gene Symbol: JAK1
3 Cross references
167 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSAMXG00000016504
Gene Symbol: JAK2
3 Cross references
198 Possible Orthologues:

Janus Kinase 2b

Ensembl ID : ENSAMXG00000014357
Gene Symbol: JAK2B
1 Cross references
194 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase B

Ensembl ID : ENSAMXG00000021777
Gene Symbol: KITB
1 Cross references
208 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).